Announcements Trials
Browse Landscape

Status

Recruiting 2Completed 2Not yet recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 5Observational 2

Sponsor

Cancer Type

Thoracic 1Gynecologic 1

Conditions

Ovarian Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Blood Specimen Collection 121Surveys and Questionnaires 82Observation 50Radiotherapy 40Drug Therapy 35Surgical Procedures, Operative 34Biopsy 31Specimen Handling 28Data Collection 27Watchful Waiting 21Interviews as Topic 20Immune Checkpoint Inhibitors 19Magnetic Resonance Imaging 18Liquid Biopsy 16Magnetic Resonance Spectroscopy 15Immunotherapy 15Standard of Care 13pembrolizumab 12Tomography, X-Ray Computed 12Ultrasonography 11trastuzumab deruxtecan 10lenvatinib 10Radiosurgery 10Nivolumab 10Carboplatin 10Tissue Banks 9Restraint, Physical 9Radiation 9Neoadjuvant Therapy 9Endoscopy 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Observational × Combined Modality Therapy × Clear all
NCT07610616 2026-05-28

Study on the Mechanism of ADC Drug Evaluation Based on Immune Co-culture of Lung Cancer Organoids

Guangzhou Institute of Respiratory Disease

Recruiting
10 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT05206890 2022-01-26

A Non-interventional Registry Study of Fluzoparib in the Treatment of Ovarian Cancer

Tongji Hospital

Recruiting
490 enrolled
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡